Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | COPD Clinical Trials in Phoenix | 149 Studies

Clinical Trials COPDPhoenix

COPD Clinical Trials in Phoenix

Find 149 clinical trials for copd near Phoenix, Arizona. Connect with research centers in your area.

All COPD trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 81-100 of 149 trials

CompletedEvaluation of the Long- Term Effects of Spiriva on Lung Function in COPD PatientsThe primary objective of this trial is to determine whether daily treatment with tiotropium (Spiriva®, Bromuro de Tiotropio®) inhalation capsule via HandiHaler® reduces the rate…NCT00144339·Anniston, Alabama and 489 others

PreviousPage 5 of 8Next

COPD Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPDThe purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.NCT00215436·Jasper, Alabama and 43 others

TerminatedBronchitis and Emphysema Advice and Training to Reduce HospitalizationEXECUTIVE SUMMARY: Purpose: To evaluate the efficacy and cost-effectiveness of a novel intervention incorporating self-management education, an action plan, and case-management…NCT00395083·Phoenix, Arizona and 21 others

CompletedAn Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to assess the effectiveness and safety of JNJ 49095397 in participants with symptomatic moderate to severe chronic obstructive pulmonary disease…NCT01867762·Phoenix, Arizona and 46 others

CompletedUS 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema StudyEvaluate the efficacy and safety of the 10 mL BLVR System in 1 or 2 treatment sessions (8 subsegments, 4 in each lung) in patients with advanced upper lobe predominant emphysema.NCT00435253·Birmingham, Alabama and 4 others

CompletedA 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)COPD is characterized by an airflow limitation, which is not fully reversible, usually progressive and accompanied by chronic cough, sputum production and dyspnea, which can be a…NCT03034915·Phoenix, Arizona and 211 others

CompletedStudy in Patients With COPDThe purpose of this study is to determine the efficacy and safety of the investigational drug in the treatment of COPD in comparison with a placebo.NCT00215449·Bessemer, Alabama and 67 others

Not yet recruitingStudy of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)The primary purpose of this study is to evaluate the safety and tolerability of treprostinil administered with a soft mist inhaler (SMI) over 16 weeks in approximately 40…NCT07923591·Birmingham, Alabama and 15 others

RecruitingA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseThis study will evaluate the effect of triple ICS/LAMA/LABA therapy with BGF MDI 320/14.4/9.6 μg on cardiopulmonary outcomes relative to LAMA/LABA therapy with GFF MDI 14.4/9.6 μg…NCT06283966·Athens, Alabama and 921 others

CompletedEfficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)This study was designed to provide 12 weeks efficacy and safety data of the 150 μg once-daily (od) dose of indacaterol in chronic obstructive pulmonary disease (COPD).NCT00624286·Anniston, Alabama and 119 others

CompletedA Pilot Study to Evaluate the ROX Anastomotic Coupler System in Patients With Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to evaluate the safety and preliminary performance of the ROX Anastomotic Coupler System (ACS), with standard of care (as defined per GOLD) in…NCT00992680·Phoenix, Arizona and 8 others

CompletedStudy Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD).This is a multi-center, randomized, double-blind, parallel-group study.NCT01957150·Jasper, Alabama and 44 others

UnknownEvaluation of Programs of Coordinated Care and Disease ManagementThis is a Congressionally mandated study.NCT00627029·Phoenix, Arizona and 14 others

CompletedEfficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)The purpose of this Phase III study is to evaluate the long-term safety and tolerability of two fixed-dose combinations of inhaled aclidinium bromide/formoterol fumarate…NCT01572792·Anniston, Alabama and 207 others

CompletedA 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPDThis is a phase III multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of GSK573719/GW642444 Inhalation Powder…NCT01313637·Jasper, Alabama and 156 others

CompletedA 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)The Purpose of this study is to assess the efficacy and safety of two strengths of the FF/GW642444 Inhalation Powder in subjects with chronic obstructive pulmonary disease (COPD)NCT01053988·Mobile, Alabama and 131 others

CompletedEfficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsThe purpose of this Phase III study is to evaluate the efficacy and safety of tozorakimab administered subcutaneously (SC) in adult participants with symptomatic COPD with a…NCT06040086·Birmingham, Alabama and 367 others

CompletedPhase 4 COPD and Suboptimal Inspiratory Flow RateStudy is a randomized, double-blind, double-dummy, parallel-group study evaluating efficacy and safety of revefenacin vs. tiotropium in adults with severe to very severe COPD and…NCT05165485·Jasper, Alabama and 75 others

CompletedStudy To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium BromidePH-797804 is an oral anti-inflammatory drug that may reduce the inflammation that is associated with Chronic Obstructive Pulmonary Disease (COPD).NCT01543919·Birmingham, Alabama and 131 others

RecruitingA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very…NCT06883305·Foley, Alabama and 304 others

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia